Skip to content

Pliant Therapeutics, Inc.

PLRX· NasdaqCore metricsCIK 1746473

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -5.21%
Market cap
$45.89M
61.99M shares
Filings
440
$0.00
FY 2025
-$24.38M
Q3 2026N/M FY25 yoy
-$25.74M
Q3 2026N/M FY25 yoy
-$49.00M
Q3 2026derivedN/M FY25 yoy
-$0.39
Q3 2026N/M FY25 yoy
$26.57M
Q3 2026−36.2% FY25 yoy
$45.89M
—
—
0.4×
-280.50%
—

FY2025 figures · derived

Price

$0.740255.94%$0.9398past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$57.05M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$1,580,000reported
FY 20222022-12-31$9,685,000reported
FY 20212021-12-31$7,572,000reported
FY 20202020-12-31$41,817,000reported
FY 20192019-12-31$57,052,000reported

Pharmaceutical preparations

Pliant Therapeutics, Inc. is the 337th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR